Rationale for targeting fibroblast growth factor receptor signaling in breast cancer Fabrice AndréJavier Cortés Review Open access 13 February 2015 Pages: 1 - 8
Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer Kathy A. ToyRajeshwari R. ValiathanCelina G. Kleer Preclinical Study 10 February 2015 Pages: 9 - 18
Prognostic significance of epithelial–mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast Jeffrey Chun Tatt LimValerie Cui Yun KohPuay Hoon Tan Preclinical study 13 February 2015 Pages: 19 - 29
Cancer stem cell and epithelial–mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast Ming Liang OonAye Aye ThikePuay Hoon Tan Preclinical Study 13 February 2015 Pages: 31 - 41
Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation Qijin XuEva Biener-RamanujanV. Krishnan Ramanujan Preclinical Study 13 February 2015 Pages: 43 - 56
Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists Nuray ErinEsra NizamSadi Köksoy Preclinical study 15 February 2015 Pages: 57 - 69
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer Michelle W. Wong-BrownCliff J. MeldrumRodney J. Scott Preclinical Study 15 February 2015 Pages: 71 - 80
DNA damage response markers are differentially expressed in BRCA-mutated breast cancers Mohammed AleskandaranyDaniela CaracappaAndrew R. Green Preclinical study Open access 19 February 2015 Pages: 81 - 90
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways Dena A. JerjeesOla H. NegmEmad A. Rakha Preclinical Study 21 February 2015 Pages: 91 - 103
The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1 Lufeng ZhengXiaoman LiTao Xi Preclinical Study 22 February 2015 Pages: 105 - 118
T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer De-di KongJie YangYan-zhen Zhou Clinical trial 13 February 2015 Pages: 119 - 126
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials Caterina FontanellaBianca LedererSibylle Loibl Clinical Trial 13 February 2015 Pages: 127 - 139
Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer Min-Ki SeongJu-Young LeeWoo Chul Noh Clinical trial 15 February 2015 Pages: 141 - 148
Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial Sirwan M. HadadPhilip CoatesAlastair M. Thompson Clinical trial 15 February 2015 Pages: 149 - 155
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy Carlos Acevedo-GadeaChristos HatzisMaysa M. Abu-Khalaf Clinical trial 17 February 2015 Pages: 157 - 167
Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D Esther K. LeeWilliam W. L. WongKelvin K. W. Chan Clinical trial 19 February 2015 Pages: 169 - 180
Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors Lusine YaghjyanGraham A. ColditzRulla M. Tamimi Epidemiology 13 February 2015 Pages: 181 - 189
Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified? N. A. de GlasC. C. EngelsJ. W. S. Merkus Epidemiology Open access 13 February 2015 Pages: 191 - 198
Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies Shanliang ZhongXiaohui ZhangJianhua Zhao Epidemiology 13 February 2015 Pages: 199 - 207
Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer Kenjiro AogiTakayuki KadoyaMorihito Okada Epidemiology Open access 20 February 2015 Pages: 209 - 217
Antihypertensive medication use and incident breast cancer in women Elizabeth E. DevoreSung KimEva S. Schernhammer Epidemiology 21 February 2015 Pages: 219 - 229